Pemigatinib (BioDeep_00000229509)
human metabolite
代谢物信息卡片
化学式: C24H27F2N5O4 (487.2031)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F
InChI: InChI=1S/C24H27F2N5O4/c1-4-30-21-14(11-27-23-16(21)9-15(28-23)13-29-5-7-35-8-6-29)12-31(24(30)32)22-19(25)17(33-2)10-18(34-3)20(22)26/h9-11H,4-8,12-13H2,1-3H3,(H,27,28)
描述信息
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
同义名列表
4 个代谢物同义名
11-(2,6-difluoro-3,5-dimethoxyphenyl)-13-ethyl-4-[(morpholin-4-yl)methyl]-5,7,11,13-tetraazatricyclo[7.4.0.0^{2,6}]trideca-1,3,6,8-tetraen-12-one; 11-(2,6-difluoro-3,5-dimethoxyphenyl)-13-ethyl-4-(morpholin-4-ylmethyl)-5,7,11,13-tetraazatricyclo[7.4.0.0^{2,6}]trideca-1,3,6,8-tetraen-12-one; Pemigatinib; Pemazyre
数据库引用编号
6 个数据库交叉引用编号
- PubChem: 86705695
- HMDB: HMDB0304863
- DrugBank: DB15102
- ChEMBL: CHEMBL4297522
- chemspider: 68007304
- CAS: 1513857-77-6
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
| 亚细胞结构定位 | 关联基因列表 |
|---|
文献列表
- Chao Zhang, Min-Na Huang, Jun-Qi Shan, Zun-Jie Hu, Zi-Wei Li, Jian-Ying Liu. Pemigatinib, a selective FGFR inhibitor overcomes ABCB1-mediated multidrug resistance in cancer cells.
Biochemical and biophysical research communications.
2024 Jan; 691(?):149314. doi:
10.1016/j.bbrc.2023.149314. [PMID: 38039831] - Tao Ji, Xuejun Chen, Swamy Yeleswaram. Evaluation of drug-drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling.
CPT: pharmacometrics & systems pharmacology.
2022 07; 11(7):894-905. doi:
10.1002/psp4.12805. [PMID: 35506332] - Zengli Liu, Jialiang Liu, Tianli Chen, Yue Wang, Anda Shi, Kangshuai Li, Xingyong Li, Bo Qiu, Lijie Zheng, Liming Zhao, Lizhuang Shu, Shuo Lian, Shaohui Huang, Zongli Zhang, Yunfei Xu. Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway.
Oncogene.
2022 05; 41(20):2885-2896. doi:
10.1038/s41388-022-02313-x. [PMID: 35428876] - Xiaohua Gong, Tao Ji, Xiang Liu, Xuejun Chen, Swamy Yeleswaram. Evaluation of the clinical cardiac safety of pemigatinib, a fibroblast growth factor receptor inhibitor, in participants with advanced malignancies.
Pharmacology research & perspectives.
2022 02; 10(1):e00906. doi:
10.1002/prp2.906. [PMID: 34951522] - Tao Ji, Kevin Rockich, Noam Epstein, Heather Overholt, Phillip Wang, Xuejun Chen, Naresh Punwani, Swamy Yeleswaram. Evaluation of the pharmacokinetics of pemigatinib in patients with impaired hepatic or renal function.
British journal of clinical pharmacology.
2022 01; 88(1):237-247. doi:
10.1111/bcp.14954. [PMID: 34169560] - Tao Ji, Kevin Rockich, Noam Epstein, Heather Overholt, Phillip Wang, Xuejun Chen, Naresh Punwani, Swamy Yeleswaram. Evaluation of drug-drug interactions of pemigatinib in healthy participants.
European journal of clinical pharmacology.
2021 Dec; 77(12):1887-1897. doi:
10.1007/s00228-021-03184-z. [PMID: 34282472] - Qinghua Weng, Wei Tan, Ren-Yue Yu, Ren-Ai Xu, Yu Chen. A novel bioanalytical method for the quantification of pemigatinib in rat plasma by UPLC-MS/MS.
Journal of pharmaceutical and biomedical analysis.
2021 Aug; 202(?):114137. doi:
10.1016/j.jpba.2021.114137. [PMID: 34015593] - Kaili Jiang, Xia Tang, Jing Guo, Rui He, Shingpan Chan, Xiaojuan Song, Zhengchao Tu, Yuting Wang, Xiaomei Ren, Ke Ding, Zhang Zhang. GZD824 overcomes FGFR1-V561F/M mutant resistance in vitro and in vivo.
Cancer medicine.
2021 07; 10(14):4874-4884. doi:
10.1002/cam4.4041. [PMID: 34114373] - R Beckerhoff, W Siegenthaler. [The value of renin determination in the diagnosis of hypertension].
Schweizerische medizinische Wochenschrift.
1976 Apr; 106(14):474-7. doi:
NULL. [PMID: 4881]
